Condition: AIHA - Warm Autoimmune Hemolytic Anemia · AIHA - Cold Autoimmune Hemolytic Anemia · ITP - Immune Thrombocytopenia · Sponsor: Lakefront Biotherapeutics West LLC
An early-phase clinical trial evaluating the safety, tolerability, and pharmacokinetics of subcutaneously dosed OM336 in adult participants with autoimmune cytopenias.
This description comes directly from the study's public registry record.
Study Sponsor · 415-429-4887 · info@ouromeds.com
Always discuss trial participation with your own doctor first.
| The Canberra Hospital | Canberra, Australian Capital Territory, Australia | Recruiting |
| Liverpool Hospital | Sydney, New South Wales, Australia | Recruiting |
| Icon Cancer Center South Brisbane | Brisbane, Queensland, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07083960